Identify and manage high-performing sites and get study results 30 days faster than the industry average with support from PharPoint’s dermatology-experienced team.
“High priority pivotal studies locked and delivered faster than any other CRO I have worked with in my experience. Not only was the study delivered within budget and early, it was a quality deliverable.”
“There is an inherent honesty and authenticity in [PharPoint’s] approach. …I have complete faith and trust in PharPoint as our partner, and that gives me confidence in the success of our clinical program.”
MEET AN EXPERT
Denise has 24+ years of experience in clinical research, during which she’s supported numerous dermatology protocols, including large, global dermatology studies.
Experience is everything. PharPoint’s senior leadership team averages over 25 years in the industry. PharPoint has supported dermatology studies for 10+ years, including Phase 1 through Phase 4. Our teammates have experience supporting dermatology studies ranging from skin infections to aesthetic dermatology indications.
DERMATOLOGY SUCCESS STORY
PharPoint provided clinical and biometrics support for a US-based Phase 1 dermatology study, ultimately meeting enrollment goals five months early – despite closures due to COVID-19.
PharPoint worked collaboratively with Sponsor, sites, and other key study partners to allow the study to progress efficiently and enroll rapidly. A specialized patient recruitment partner was brought on, providing additional enrollment support to study sites. PharPoint’s attentive, supportive site relationships kept us – and the study Sponsor – in front-row seats to study progress, closely monitoring and responding to missed visits.
The result? A study that overcame difficult challenges and managed to enroll 5 months ahead of schedule.
Identify and activate the perfect sites:
PharPoint uses big data & CTMS alongside our growing internal investigator database to pinpoint dermatology sites with proven success. As part of our identification and analysis process, we provide Sponsors with a heatmap that consists of potential North American site locations and prospective available patient populations.
PharPoint’s proprietary Enrollment Index projects a site’s ability to enroll patients based on patient availability, site resources, and competing trials. Based on your needs, PharPoint can anticipate the number of sites you’ll need to meet enrollment goals, including customized site number and duration models.
With PharPoint as your Dermatology CRO, you’ll experience our team’s industry-best biometrics timelines. PharPoint can lock a database as soon as five days after LPLV SDV – approximately one month faster than the industry average, with topline results to follow only two days after.
Central Abdominal Bulging
Cutaneous Lupus Erythematosus
Herpes Labialis Infection
Localized Abdominal Contour Defects
Lower Limb and Foot Ulcers
Subcutaneous Adipose Tissue Reduction
Submental Subcutaneous Fat
Venous Leg Ulcers
PharPoint works diligently on behalf of and alongside your team for a seamless study experience.
Top-of-mind and always accessible:
Unlike big-box CROs that can leave smaller Sponsors feeling overlooked and forgotten, PharPoint looks at Sponsor-CRO relationships as a partnership, prioritizing your study data and goals. This includes a clear escalation path.
PharPoint’s study team works cross-functionally, avoiding silos. With different departments working together, expertise is shared, questions can be addressed promptly, and a trial’s many moving parts can work like a well-oiled machine.